🔎 Trials Near Me

Akèy › Leukemi › Alabama

Etid klinik pou Leukemi nan Alabama

10 etid pou Leukemi ap chèche patisipan nan sit nan Alabama.

Vil nan Alabama

Tèks ofisyèl etid la (Anglè)

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 16, Birmingham
Ap rekriteFaz 3
Laj 18 a 71 · Tout sèks · Mizajou Sep 23, 2026 · NCT07504458

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

  • University of Alabama - Birmingham, Birmingham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06824168

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

  • Dren Investigational Site, Birmingham
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Children's Hospital of Alabama, Birmingham
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

  • University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Mar 4, 2026 · NCT07044544

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Birmingham
  • Massive Bio SYNERGY-AI site, Mobile
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

  • University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 8, 2025 · NCT06265584

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

  • University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Oct 8, 2025 · NCT06315309

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Nov 15, 2024 · NCT06034275

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.